The Experiences of People Who Live With Glanzmanns Thrombasthenia.
NCT05315232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122
Last updated 2024-03-13
Summary
To understand the lived experiences of people with Glanzmanns Thrombasthenia
Conditions
- Glanzmann Thrombasthenia
Interventions
- OTHER
-
survey and interview
qualitative assessment
Sponsors & Collaborators
-
Hemab ApS
collaborator INDUSTRY -
Haemnet
lead OTHER
Principal Investigators
-
Mike Holland, BSC · Haemnet
Eligibility
- Min Age
- 0 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-27
- Primary Completion
- 2023-04-27
- Completion
- 2023-04-27
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
NCT05130424 ·Status: UNKNOWN
-
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
NCT06792019 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies
NCT02222545 ·Status: COMPLETED ·Phase: PHASE2
-
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
NCT05389007 ·Status: UNKNOWN
-
Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada
NCT03784898 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects
NCT05088642 ·Status: COMPLETED ·Phase: PHASE1
-
Aplastic Anemia Epidemiology: Incidence and Case-control
NCT00005682 ·Status: COMPLETED
-
ITP Registry and Accompanying Biospecimen Collection
NCT05152238 ·Status: RECRUITING
-
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
NCT05394285 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan
NCT01876745 ·Status: COMPLETED
-
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
NCT02838992 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
NCT07286032 ·Status: RECRUITING ·Phase: PHASE3
-
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
NCT03638817 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
NCT01152229 ·Status: COMPLETED
-
Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 ·Status: RECRUITING
-
Lovaza's Effect on the Activation of Platelets
NCT00515541 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
NCT02065882 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302 ·Status: COMPLETED
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
NCT00861692 ·Status: COMPLETED ·Phase: PHASE2
-
Heparin-Induced Thrombocytopenia Registry
NCT00456326 ·Status: COMPLETED
-
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
NCT06562738 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
NCT02773290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
NCT03102593 ·Status: COMPLETED ·Phase: PHASE2